Search research articles
Contact Us
Filters
Showing results (81-90 of 231) with videos related to
Page
of 24
Sort By:
International Journal of Molecular Sciences
|
January 10, 2026
Cannabinoid Signaling and Autophagy in Oral Disease: Molecular Mechanisms and Therapeutic Implications
Undral Munkhsaikhan, Md Ataur Rahman, Alivia Shasteen, et al.
Blood
|
September 30, 2010
Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232)
Jeffrey A Zonder, John Crowley, Mohamad A Hussein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 13, 2025
Unraveling the oral microbiome's role in Alzheimer's disease: From pathophysiology to therapeutic potential
Gilliana Rozenblum, Karima Ait-Aissa, Gadeer Zahran, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 14, 2015
BEAM Conditioning Regimen Has Higher Toxicity Compared With High-Dose Melphalan for Salvage Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
Muthu Veeraputhiran, Tania Jain, Abhinav Deol, et al.
The Journal of Contemporary Dental Practice
|
March 28, 2022
Socket-shield Technique: A Systematic (Scoping) Review of Case Series and Case Reports
Fuad A Al-Sanabani, Nazim H Abidi, Manea M Al-Ahmari, et al.
Bone Marrow Transplantation
|
April 12, 2005
Safety of low-dose low-molecular-weight-heparins in thrombocytopenic stem cell transplantation patients: a case series and review of the literature
R B Ibrahim, E Peres, R Dansey, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 18, 2013
Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma
Divaya Bhutani, Jeffrey Zonder, Jason Valent, et al.
Journal of Clinical Apheresis
|
April 5, 2014
Successful hematopoietic stem cell collection in patients who fail initial plerixafor mobilization for autologous stem cell transplant
Muthu Veeraputhiran, Tania Jain, Simon Cronin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 29, 2012
Melphalan 180 mg/m2 can be safely administered as conditioning regimen before an autologous stem cell transplantation (ASCT) in multiple myeloma patients with creatinine clearance 60 mL/min/1.73 m2 or lower with use of palifermin for cytoprotection: results of a phase I trial
Muneer H Abidi, Rishi Agarwal, Lois Ayash, et al.
Animals : an Open Access Journal From MDPI
|
December 11, 2025
The Role of Short-Chain Fatty Acids (SCFAs) in Colic and Anti-Inflammatory Pathways in Horses
Nathan Schank, Ashley Cottone, Michelle Wulf, et al.
Page
of 24
Search research articles
Search
Showing results (81-90 of 231) with videos related to
Sort By:
Page
of 24
International Journal of Molecular Sciences
|
January 10, 2026
Cannabinoid Signaling and Autophagy in Oral Disease: Molecular Mechanisms and Therapeutic Implications
Undral Munkhsaikhan, Md Ataur Rahman, Alivia Shasteen, et al.
Blood
|
September 30, 2010
Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232)
Jeffrey A Zonder, John Crowley, Mohamad A Hussein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 13, 2025
Unraveling the oral microbiome's role in Alzheimer's disease: From pathophysiology to therapeutic potential
Gilliana Rozenblum, Karima Ait-Aissa, Gadeer Zahran, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 14, 2015
BEAM Conditioning Regimen Has Higher Toxicity Compared With High-Dose Melphalan for Salvage Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
Muthu Veeraputhiran, Tania Jain, Abhinav Deol, et al.
The Journal of Contemporary Dental Practice
|
March 28, 2022
Socket-shield Technique: A Systematic (Scoping) Review of Case Series and Case Reports
Fuad A Al-Sanabani, Nazim H Abidi, Manea M Al-Ahmari, et al.
Bone Marrow Transplantation
|
April 12, 2005
Safety of low-dose low-molecular-weight-heparins in thrombocytopenic stem cell transplantation patients: a case series and review of the literature
R B Ibrahim, E Peres, R Dansey, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 18, 2013
Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma
Divaya Bhutani, Jeffrey Zonder, Jason Valent, et al.
Journal of Clinical Apheresis
|
April 5, 2014
Successful hematopoietic stem cell collection in patients who fail initial plerixafor mobilization for autologous stem cell transplant
Muthu Veeraputhiran, Tania Jain, Simon Cronin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 29, 2012
Melphalan 180 mg/m2 can be safely administered as conditioning regimen before an autologous stem cell transplantation (ASCT) in multiple myeloma patients with creatinine clearance 60 mL/min/1.73 m2 or lower with use of palifermin for cytoprotection: results of a phase I trial
Muneer H Abidi, Rishi Agarwal, Lois Ayash, et al.
Animals : an Open Access Journal From MDPI
|
December 11, 2025
The Role of Short-Chain Fatty Acids (SCFAs) in Colic and Anti-Inflammatory Pathways in Horses
Nathan Schank, Ashley Cottone, Michelle Wulf, et al.
Page
of 24